Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px
Organisation › Details

Apeiron (Group)

APEIRON is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. The company is developing immunotherapies, predominantly in clinical stage, based either on targeted, tumor-specific approaches or on the stimulation of the immune system via novel and proprietary modes of action (unique checkpoint blockade mechanisms) to fight cancer by engaging the human body’s natural defence mechanisms. *

 

Period Start 2012-10-17 established
Product Industry cancer immunotherapy (immuno-oncology, I-O)
Persons Person Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex)
  Person 2 Loibner, Hans (Apeiron Biologics 200810–201807 CEO RETIRED 7/18 continues as senior advisor)
     
Region Region Wien (Vienna)
  Country Austria
  Street 5 Campus-Vienna-Biocenter
  City 1030 Wien
  Tel +43-1-865-6577
    Address record changed: 2018-07-24
     
Basic data Employees B: 11 to 50 (2015-09-22)
     
    * Document for �About Section�: Apeiron Biologics AG. (7/17/18). "Press Release: Apeiron Appoints Peter Llewellyn-Davies as Chief Executive Officer". Vienna.
     
   
Record changed: 2018-07-18

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Apeiron (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px




» top